Finnish blood testing startup Nightingale is looking to solve the global burden of chronic disease. With interest in blood-testing startups growing, I sat down with CEO Teemu Suna to find out how they plan on building personalized healthcare, and how the Theranos fraud case has affected them.
Finnish Blood Testing Startup Is Going Beyond The Theranos Dream
